세계의 구더기 제거(Maggot Debridement) 시장 규모, 점유율, 동향 분석 리포트 : 투여법별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Maggot Debridement Market Size, Share & Trends Analysis Report By Administration (Loose Larva, Biobags), By Application (Acute Wounds, Chronic Wounds), By End-use (Hospital, Clinics), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,515,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,946,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,809,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

구더기 제거(Maggot Debridement) 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 구더기 제거 시장 규모는 2030년까지 2,570만 달러에 달하며, 2025-2030년에 10.3%의 CAGR로 성장할 것으로 추정되고 있습니다. R&D 투자 증가, 만성질환의 유병률 증가, 화상 사례 증가가 시장의 주요 촉진요인입니다.

최근 전 세계에서 수술 건수가 증가하고 있습니다. 암, 당뇨병, 자가면역질환 등 만성질환의 유병률 증가는 국내 수술 건수 증가의 주요 원인 중 하나입니다. 감염성 및 비감염성 질환의 발병률은 지난 수십년간 증가하고 있습니다.

이는 도시화, 대부분의 개발도상국의 국경을 초월한 빈곤, 항균제 내성, 식품 매개 질병의 유병률 증가 등의 요인에 기인합니다. CDC의 추정에 따르면 2017년 미국에서는 1억 명 이상의 사람들이 당뇨병을 앓고 있으며, 2017년 현재 미국에서는 1억 명 이상의 사람들이 당뇨병을 앓고 있습니다.

2형 당뇨병은 가장 흔한 당뇨병으로, 전체 인구의 90.0%가 2형 당뇨병을 앓고 있습니다. 당뇨병의 흔한 합병증 인 당뇨병성 족부 궤양은 일반적으로 발 절단을 예방하기 위해 상처 드레싱이나 외과적 개입이 필요합니다. 따라서 만성 상처 증가로 인해 구더기 제거에 대한 수요가 증가할 것으로 예상됩니다.

구더기 제거 시장 보고서 하이라이트

• 바이오백 부문은 상처 치유를 촉진하는 데 효과적임이 입증되었으며, 사용 편의성으로 인해 2024년 76.5%의 최대 매출 점유율을 차지하며 시장을 장악했습니다.
• 만성 상처 부문은 2024년 59.9%의 가장 큰 매출 점유율을 차지하며 시장을 장악했습니다. 이는 주로 당뇨병성 족부 궤양, 관절염, 욕창과 같은 만성 상처 증가로 인해 당뇨병 및 말초 혈관 질환과 같은 합병증을 앓고 있는 노인 및 개인에서 흔히 볼 수 있습니다.
• 병원 부문이 2024년 45.4%의 가장 큰 매출 점유율을 차지하며 시장을 장악했습니다. 이는 만성적으로 치유되지 않는 상처와 심각한 조직 손상을 입은 환자에게 종합적인 상처 치료를 제공하는 중요한 역할을 담당하고 있기 때문입니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 구더기 제거 시장 변수, 동향, 범위

• 시장 서론/계통 전망
• 시장 규모와 성장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 구더기 제거 시장 분석 툴
  • Porter의 산업 분석
  • PESTEL 분석

제4장 구더기 제거 시장 : 투여법 추정·동향 분석

• 투여법 시장 점유율(2024년·2030년)
• 투여법 부문 대시보드
• 시장 규모와 예측·동향 분석 : 투여법별(2018-2030년)
• Loose Larva
• 바이오 백

제5장 구더기 제거 시장 : 용도 추정·동향 분석

• 용도의 시장 점유율(2024년·2030년)
• 용도의 부문 대시보드
• 시장 규모와 예측·동향 분석 : 용도별(2018-2030년)
• 급성 창상
• 만성 창상

제6장 구더기 제거 시장 : 최종 용도 추정·동향 분석

• 최종 용도의 시장 점유율(2024년·2030년)
• 최종 용도의 부문 대시보드
• 시장 규모와 예측·동향 분석 : 최종 용도별(2018-2030년)
• 병원
• 클리닉
• 창상관리 센터
• 기타

제7장 구더기 제거 시장 : 지역 추정·동향 분석

• 지역별 시장 점유율 분석(2024년·2030년)
• 지역의 시장 대시보드
• 시장 규모와 예측 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 참여 기업 개요
• 기업의 시장 현황 분석
• 기업 분류
• 전략 지도제작
• 기업 개요/상장기업
  • BioMonde
  • Monarch Labs
  • Mega Pharma(Pvt) Ltd.
  • Smith &Nephew
  • Coloplast
  • B. Braun Melsungen AG
  • Molnlycke Healthcare
  • Lohmann &Rauscher
  • Arobella Medical

KSA

영문 목차

영문목차

Maggot Debridement Market Growth & Trends:

The global maggot debridement market size is estimated to reach USD 25.7 million by 2030, registering to grow at a CAGR of 10.3% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising investment in research and development, growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.

In the recent past, there has been a rise in the number of surgical procedures across the globe. Rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune diseases, is one of the key factors leading to an increase in the number of surgeries being performed in the country. The incidence of infectious and non-communicable diseases has increased over the past few decades.

This can be attributed to factors such as urbanization, borderline poverty in most developing states, antimicrobial resistance, and rising prevalence of food-borne diseases. An unhealthy lifestyle, lack of physical activity, alcohol abuse, and smoking are some of the major factors contributing to the rising prevalence of the abovementioned diseases. According to CDC estimates, in 2017, more than 100.0 million people were living with diabetes in the U.S.

Type II diabetes is the most common type of diabetes and 90.0% of the affected population is suffering from type II diabetes. Diabetic foot ulcer, a common complication of diabetes, typically requires wound debridement and surgical intervention to prevent foot amputation. Thus, a rising number of chronic wounds are anticipated to increase the demand for maggot debridement.

Maggot Debridement Market Report Highlights:

• The biobags segment dominated the market with the largest revenue share of 76.5% in 2024 owing to its ease of use, which has proven effective in promoting wound healing.
• The chronic wounds segment dominated the market and accounted for the largest revenue share of 59.9% in 2024, largely due to a rise in chronic wounds, such as diabetic foot ulcers, arthritis, and pressure ulcers, which are more common in older people and individuals with comorbidities such as diabetes and peripheral vascular diseases.
• Hospitals dominated the market and accounted for the largest revenue share of 45.4% in 2024, driven by their critical role in providing comprehensive wound care for patients with chronic, non-healing wounds and severe tissue damage.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Maggot Debridement Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Maggot Debridement Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Maggot Debridement Market: Administration Estimates & Trend Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Administration, 2018 to 2030 (USD Million)
• 4.4. Loose Larva
  • 4.4.1. Loose Larva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Biobags
  • 4.5.1. Biobags Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Maggot Debridement Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Acute Wounds
  • 5.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.1.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.1.2. Burns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Chronic Wounds
  • 5.5.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.2. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.3. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.1.4. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Maggot Debridement Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospital
  • 6.4.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Clinics
  • 6.5.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Wound Care Centers
  • 6.6.1. Wound Care Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Maggot Debridement Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 7.4. North America
  • 7.4.1. North America Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Denmark Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Sweden Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Norway Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. Australia Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. South Korea Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East and Africa
  • 7.8.1. Middle East and Africa Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Maggot Debridement Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. BioMonde
    • 8.5.1.1. Participant's Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Recent Developments/ Strategic Initiatives
  • 8.5.2. Monarch Labs
    • 8.5.2.1. Participant's Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Recent Developments/ Strategic Initiatives
  • 8.5.3. Mega Pharma (Pvt) Ltd.
    • 8.5.3.1. Participant's Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Recent Developments/ Strategic Initiatives
  • 8.5.4. Smith & Nephew
    • 8.5.4.1. Participant's Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Recent Developments/ Strategic Initiatives
  • 8.5.5. Coloplast
    • 8.5.5.1. Participant's Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Recent Developments/ Strategic Initiatives
  • 8.5.6. B. Braun Melsungen AG
    • 8.5.6.1. Participant's Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Recent Developments/ Strategic Initiatives
  • 8.5.7. Molnlycke Healthcare
    • 8.5.7.1. Participant's Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Recent Developments/ Strategic Initiatives
  • 8.5.8. Lohmann & Rauscher
    • 8.5.8.1. Participant's Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Recent Developments/ Strategic Initiatives
  • 8.5.9. Arobella Medical
    • 8.5.9.1. Participant's Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking

관련자료